Indo US Bio-TechNSE:INDOUS -2.29%63 PB Ratio is 1.90 as of Jul. 11, 2026, which is 55% below its 10-year median of 4.19. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹312.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 246 Agriculture companies, Indo US Bio-Tech ranks worse than 63.01% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Indo US Bio-Tech's share price is ₹87.52. Indo US Bio-Tech's Book Value per Share for the quarter that ended in Mar. 2026 was ₹46.15. Hence, Indo US Bio-Tech's PB Ratio of today is 1.90.
Good Sign:
Indo US Bio-Tech Ltd stock PB Ratio (=1.94) is close to 5-year low of 1.92.
The historical rank and industry rank for Indo US Bio-Tech's PB Ratio or its related term are showing as below:
NSE:INDOUS'
s PB Ratio Range Over the Past 10 Years
Min: 1.86 Med: 4.19 Max: 10.3
Current: 1.86
During the past 13 years, Indo US Bio-Tech's highest PB Ratio was 10.30. The lowest was 1.86. And the median was 4.19.
NSE:INDOUS's PB Ratio is ranked worse than 63.01% of 246
companies
in the Agriculture industry
Industry Median: 1.5
vs NSE:INDOUS: 1.86
During the past 12 months, Indo US Bio-Tech's average Book Value Per Share Growth Rate was 17.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 19.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 24.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 33.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Indo US Bio-Tech was 49.20% per year. The lowest was 18.50% per year. And the median was 28.80% per year.
Back to Basics: PB Ratio
Indo US Bio-Tech (NSE:INDOUS) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Indo US Bio-Tech PB Ratio Related Terms
Indo US Bio-Tech PB Ratio Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Indo US Bio-Tech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech PB Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's PB Ratio distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Indo US Bio-Tech (NSE:INDOUS) has a PB Ratio of 1.90 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Indo US Bio-Tech and its competitors. This is 55% below median its historical median of 4.19. Over the past decade, Indo US Bio-Tech's PB Ratio has ranged from 1.86 to 10.30. According to the industry distribution chart, Indo US Bio-Tech ranks #155 out of 246 companies in the Agriculture industry, placing it in the top 63%.
Is Indo US Bio-Tech's PB Ratio too high?
Indo US Bio-Tech's current PB Ratio of 1.90 is 55% below median its 10-year median of 4.19. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 10.30. The Agriculture industry median PB Ratio is 1.50. Indo US Bio-Tech's value of 1.90 is 26.7% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #155 out of 246 companies in the Agriculture industry, which is below the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's PB Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #155 out of 246 companies for PB Ratio. This places Indo US Bio-Tech in the lower half of its industry. The industry median PB Ratio is 1.50. Indo US Bio-Tech's value of 1.90 is 26.7% above this benchmark. Historically, Indo US Bio-Tech's own PB Ratio has ranged from 1.86 to 10.30 over the past decade. While the company's 10-year median is 4.19 vs. the industry median of 1.50, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Agriculture company?
The median PB Ratio among Agriculture companies is 1.50, based on 246 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current PB Ratio of 1.90 is 26.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median PB Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current PB Ratio is 1.90, which is 55% below median its own 10-year median of 4.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹312.23, compared to a current price of ₹87.52 — trading 72% below its estimated fair value. The current PB Ratio is 1.90, which is 55% below median its 10-year median of 4.19 and 26.7% above the Agriculture industry median of 1.50. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current PB Ratio is 1.90 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹87.52 is trading 72% below its estimated GF Value™ of ₹312.23.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
PB Ratio: 1.90 (55% below median its 10-year median of 4.19)
GF Value™: ₹312.23 vs. price of ₹87.52 (72% below fair value)
Industry Position: 26.7% above the Agriculture median (#155 of 246)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
